Risk of Major Bleeding
|0 points:||2% @ 3 mo’s, 3% @ 12 mo’s|
|1-2 points:||5% @ 3 mo’s, 12% @ 12 mo’s|
|3-4 points:||23% @ 3 mo’s, 48% @ 12 mo’s|
- Kearon CGent MHirsh J et al. Extended anticoagulation compared to placebo after three months of therapy for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999;340901- 907
- Wells PS, Forgie MA, Simms M, et al. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for DVT and PE. Arch Intern Med. 2003; 163: 917-20.
- Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med. 1998 Aug;105(2):91-99.
ThePhysician.org includes risk tools and content intended for use by healthcare professionals. These tools do not give professional advice; physicians and other healthcare professionals who use these tools or databases should exercise their own clinical judgment as to the information they provide.
Please read Disclaimer for additional information